The DOI matches its Crossref record; 220 of the 220 references it cites were found in a registry or an index.
Targeting proteinase-activated receptors: therapeutic potential and challenges
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vu, T.-K. H., Hung, D. T., Wheaton, V. I., & Coughlin, S. R. (1991) · Cell · doi:10.1016/0092-8674(91)90261-v · Cited by 2,970
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Protease‐activated receptors in hemostasis, thrombosis and vascular biology
COUGHLIN, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01377.x · Cited by 1,035
A dual thrombin receptor system for platelet activation
Kahn, M. L., Zheng, Y.-W., Huang, W., Bigornia, V., Zeng, D., Moff, S., Farese, R. V., Tam, C., & Coughlin, S. R. (1998) · Nature · doi:10.1038/29325 · Cited by 979
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
Steinhoff, M., Vergnolle, N., Young, S. H., Tognetto, M., Amadesi, S., Ennes, H. S., Trevisani, M., Hollenberg, M. D., Wallace, J. L., Caughey, G. H., et al. (2000) · Nature Medicine · doi:10.1038/72247 · Cited by 936
Self-citationMolecular cloning of a potential proteinase activated receptor.
Nystedt, S., Emilsson, K., Wahlestedt, C., & Sundelin, J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9208 · Cited by 886
Protease-activated receptor 3 is a second thrombin receptor in humans
Ishihara, H., Connolly, A. J., Zeng, D., Kahn, M. L., Wu Zheng, Y., Timmons, C., Tram, T., & Coughlin, S. R. (1997) · Nature · doi:10.1038/386502a0 · Cited by 865
Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin
Kahn, M. L., Nakanishi-Matsui, M., Shapiro, M. J., Ishihara, H., & Coughlin, S. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6042 · Cited by 841
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway
Riewald, M., Petrovan, R. J., Donner, A., Mueller, B. M., & Ruf, W. (2002) · Science · doi:10.1126/science.1071699 · Cited by 831
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 825
Cloning and characterization of human protease-activated receptor 4
Xu, W.-F., Andersen, H., Whitmore, T. E., Presnell, S. R., Yee, D. P., Ching, A., Gilbert, T., Davie, E. W., & Foster, D. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6642 · Cited by 817
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
Tricoci, P., Huang, Z., Held, C., Moliterno, D. J., Armstrong, P. W., Van de Werf, F., White, H. D., Aylward, P. E., Wallentin, L., Chen, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109719 · Cited by 754
Regulation of GPCRs by Endocytic Membrane Trafficking and Its Potential Implications
Hanyaloglu, A. C., & Zastrow, M. V. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094830 · Cited by 609
Role for protease activity in visceral pain in irritable bowel syndrome
Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29255 · Cited by 591 · cited 1×
“In addition, increased levels of PAR2-activating serine proteinases have been detected in patients with inflammatory bowel diseas”
BackgroundKenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
PAR3 is a cofactor for PAR4 activation by thrombin
Nakanishi-Matsui, M., Zheng, Y.-W., Sulciner, D. J., Weiss, E. J., Ludeman, M. J., & Coughlin, S. R. (2000) · Nature · doi:10.1038/35007085 · Cited by 557
Proteolytic Enzymes Initiating Cell Division and Escape from Contact Inhibition of Growth
BURGER, M. M. (1970) · Nature · doi:10.1038/227170a0 · Cited by 507
Functional Selectivity and Biased Receptor Signaling
Kenakin, T. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 505
Feistritzer, C., & Riewald, M. (2005) · Blood · doi:10.1182/blood-2004-10-3985 · Cited by 475
Mitogenic activity of blood components. I. Thrombin and prothrombin.
Chen, L. B., & Buchanan, J. M. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.1.131 · Cited by 473
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
Vergnolle, N., Bunnett, N. W., Sharkey, K. A., Brussee, V., Compton, S. J., Grady, E. F., Cirino, G., Gerard, N., Basbaum, A. I., Andrade-Gordon, P., et al. (2001) · Nature Medicine · doi:10.1038/89945 · Cited by 465
Self-citationG Protein–Coupled Receptor Sorting to Endosomes and Lysosomes
Marchese, A., Paing, M. M., Temple, B. R. S., & Trejo, J. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094646 · Cited by 456
Thrombin receptor overexpression in malignant and physiological invasion processes
Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., & Bar-Shavit, R. (1998) · Nature Medicine · doi:10.1038/nm0898-909 · Cited by 417
Asokananthan, N., Graham, P. T., Fink, J., Knight, D. A., Bakker, A. J., McWilliam, A. S., Thompson, P. J., & Stewart, G. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3577 · Cited by 388
Induction of Intestinal Inflammation in Mouse by Activation of Proteinase-Activated Receptor-2
Cenac, N., Coelho, A.-M., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W. K., Wallace, J. L., Hollenberg, M. D., Bunnett, N. W., Garcia-Villar, R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 378
Self-citationStructure, function and pathophysiology of protease activated receptors
Adams, M. N., Ramachandran, R., Yau, M.-K., Suen, J. Y., Fairlie, D. P., Hollenberg, M. D., & Hooper, J. D. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.003 · Cited by 370
Self-citationEssential role for proteinase-activated receptor-2 in arthritis
Ferrell, W. R., Lockhart, J. C., Kelso, E. B., Dunning, L., Plevin, R., Meek, S. E., Smith, A. J. H., Hunter, G. D., McLean, J. S., McGarry, F., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16913 · Cited by 362
Asokananthan, N., Graham, P. T., Stewart, D. J., Bakker, A. J., Eidne, K. A., Thompson, P. J., & Stewart, G. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4572 · Cited by 359
A protective role for protease-activated receptors in the airways
Cocks, T. M., Fong, B., Chow, J. M., Anderson, G. P., Frauman, A. G., Goldie, R. G., Henry, P. J., Carr, M. J., Hamilton, J. R., & Moffatt, J. D. (1999) · Nature · doi:10.1038/18223 · Cited by 357
Cathepsin G Activates Protease-activated Receptor-4 in Human Platelets
Sambrano, G. R., Huang, W., Faruqi, T., Mahrus, S., Craik, C., & Coughlin, S. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.6819 · Cited by 345
Nystedt, S., Emilsson, K., Larsson, A., Strömbeck, B., & Sundelin, J. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20784.x · Cited by 339
Release from Density Dependent Growth Inhibition by Proteolytic Enzymes
Sefton, B. M., & Rubin, H. (1970) · Nature · doi:10.1038/227843a0 · Cited by 335
Schmidlin, F., Amadesi, S., Dabbagh, K., Lewis, D. E., Knott, P., Bunnett, N. W., Gater, P. R., Geppetti, P., Bertrand, C., & Stevens, M. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5315 · Cited by 324
Scotton, C. J., Krupiczojc, M. A., Königshoff, M., Mercer, P. F., Lee, Y. C. G., Kaminski, N., Morser, J., Post, J. M., Maher, T. M., Nicholson, A. G., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33288 · Cited by 319
Luminal trypsin may regulate enterocytes through proteinase-activated receptor 2
Kong, W., McConalogue, K., Khitin, L. M., Hollenberg, M. D., Payan, D. G., Böhm, S. K., & Bunnett, N. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8884 · Cited by 318
Self-citationGecse, K., Róka, R., Ferrier, L., Leveque, M., Eutamene, H., Cartier, C., Ait-Belgnaoui, A., Rosztóczy, A., Izbéki, F., Fioramonti, J., et al. (2008) · Gut · doi:10.1136/gut.2007.140210 · Cited by 314
Covic, L., Gresser, A. L., Talavera, J., Swift, S., & Kuliopulos, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022460899 · Cited by 314
Mast cell tryptase stimulates human lung fibroblast proliferation via protease-activated receptor-2
Akers, I. A., Parsons, M., Hill, M. R., Hollenberg, M. D., Sanjar, S., Laurent, G. J., & McAnulty, R. J. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.1.l193 · Cited by 308
Self-citationBiphasic Kinetics of Activation and Signaling for PAR1 and PAR4 Thrombin Receptors in Platelets
Covic, L., Gresser, A. L., & Kuliopulos, A. (2000) · Biochemistry · doi:10.1021/bi9927078 · Cited by 306
Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more
Ramachandran, R., & Hollenberg, M. D. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707507 · Cited by 305
Self-citationDonovan, F. M., Pike, C. J., Cotman, C. W., & Cunningham, D. D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05316.1997 · Cited by 304
Becker, R. C., Moliterno, D. J., Jennings, L. K., Pieper, K. S., Pei, J., Niederman, A., Ziada, K. M., Berman, G., Strony, J., Joseph, D., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60230-0 · Cited by 299
Thrombin Responses in Human Endothelial Cells
O'Brien, P. J., Prevost, N., Molino, M., Hollinger, M. K., Woolkalis, M. J., Woulfe, D. S., & Brass, L. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13502 · Cited by 297
Scarborough, R. M., Naughton, M. A., Teng, W., Hung, D. T., Rose, J., Vu, T. K., Wheaton, V. I., Turck, C. W., & Coughlin, S. R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42184-9 · Cited by 286
Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation
Covic, L., Misra, M., Badar, J., Singh, C., & Kuliopulos, A. (2002) · Nature Medicine · doi:10.1038/nm760 · Cited by 275
Vaughan, P., Pike, C., Cotman, C., & Cunningham, D. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05389.1995 · Cited by 272
Chackalamannil, S., Wang, Y., Greenlee, W. J., Hu, Z., Xia, Y., Ahn, H.-S., Boykow, G., Hsieh, Y., Palamanda, J., Agans-Fantuzzi, J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800180e · Cited by 269
Lee, E.-J., Woo, M.-S., Moon, P.-G., Baek, M.-C., Choi, I.-Y., Kim, W.-K., Junn, E., & Kim, H.-S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903480 · Cited by 267
Wright, K. L., Duncan, M., & Sharkey, K. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 264
The mobile receptor hypothesis and “cooperativity” of hormone binding. Application to insulin
Jacobs, S., & Cuatrecasas, P. (1976) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(76)90275-3 · Cited by 253
Mechanisms of Desensitization and Resensitization of Proteinase-activated Receptor-2
Bühm, S. K., Khitin, L. M., Grady, E. F., Aponte, G., Payan, D. G., & Bunnett, N. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.36.22003 · Cited by 250
Activated Protein C Prevents Neuronal Apoptosis via Protease Activated Receptors 1 and 3
Guo, H., Liu, D., Gelbard, H., Cheng, T., Insalaco, R., Fernández, J. A., Griffin, J. H., & Zlokovic, B. V. (2004) · Neuron · doi:10.1016/s0896-6273(04)00019-4 · Cited by 247
Proteinase-activated Receptors, Targets for Kallikrein Signaling
Oikonomopoulou, K., Hansen, K. K., Saifeddine, M., Tea, I., Blaber, M., Blaber, S. I., Scarisbrick, I., Andrade-Gordon, P., Cottrell, G. S., Bunnett, N. W., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513138200 · Cited by 247
Self-citationTrivedi, V., Boire, A., Tchernychev, B., Kaneider, N. C., Leger, A. J., O'Callaghan, K., Covic, L., & Kuliopulos, A. (2009) · Cell · doi:10.1016/j.cell.2009.02.018 · Cited by 246
Shapiro, M. J., Weiss, E. J., Faruqi, T. R., & Coughlin, S. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004589200 · Cited by 246
Hollenberg, M. D., Saifeddine, M., Al‐Ani, B., & Kawabata, A. (1997) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-75-7-832 · Cited by 242
Self-citation'Role reversal' for the receptor PAR1 in sepsis-induced vascular damage
Kaneider, N. C., Leger, A. J., Agarwal, A., Nguyen, N., Perides, G., Derian, C., Covic, L., & Kuliopulos, A. (2007) · Nature Immunology · doi:10.1038/ni1525 · Cited by 233
Chambers, R. C., Leoni, P., Blanc-Brude, O. P., Wembridge, D. E., & Laurent, G. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003188200 · Cited by 233
The Distinct Roles of Two GPCRs, MrgprC11 and PAR2, in Itch and Hyperalgesia
Liu, Q., Weng, H.-J., Patel, K. N., Tang, Z., Bai, H., Steinhoff, M., & Dong, X. (2011) · Science Signaling · doi:10.1126/scisignal.2001925 · Cited by 230
Paing, M. M., Stutts, A. B., Kohout, T. A., Lefkowitz, R. J., & Trejo, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109160200 · Cited by 229
Ishii, K., Chen, J., Ishii, M., Koch, W. J., Freedman, N. J., Lefkowitz, R. J., & Coughlin, S. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42230-7 · Cited by 223
Blocking the Protease-Activated Receptor 1-4 Heterodimer in Platelet-Mediated Thrombosis
Leger, A. J., Jacques, S. L., Badar, J., Kaneider, N. C., Derian, C. K., Andrade-Gordon, P., Covic, L., & Kuliopulos, A. (2006) · Circulation · doi:10.1161/circulationaha.105.587758 · Cited by 218
Howell, D. C. J., Johns, R. H., Lasky, J. A., Shan, B., Scotton, C. J., Laurent, G. J., & Chambers, R. C. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62354-1 · Cited by 218
Vergnolle, N., Hollenberg, M. D., Sharkey, K. A., & Wallace, J. L. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702634 · Cited by 217
Self-citationJunge, C. E., Sugawara, T., Mannaioni, G., Alagarsamy, S., Conn, P. J., Brat, D. J., Chan, P. H., & Traynelis, S. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235594100 · Cited by 199
Bogatkevich, G. S., Tourkina, E., Silver, R. M., & Ludwicka-Bradley, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106441200 · Cited by 196
Fiorucci, S., Mencarelli, A., Palazzetti, B., Distrutti, E., Vergnolle, N., Hollenberg, M. D., Wallace, J. L., Morelli, A., & Cirino, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241377298 · Cited by 195
Self-citationBernett, M. J., Blaber, S. I., Scarisbrick, I. A., Dhanarajan, P., Thompson, S. M., & Blaber, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202392200 · Cited by 194
Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation
Kelso, E. B., Lockhart, J. C., Hembrough, T., Dunning, L., Plevin, R., Hollenberg, M. D., Sommerhoff, C. P., McLean, J. S., & Ferrell, W. R. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093807 · Cited by 194
Self-citationStriggow, F., Riek‐Burchardt, M., Kiesel, A., Schmidt, W., Henrich‐Noack, P., Breder, J., Krug, M., Reymann, K. G., & Reiser, G. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01676.x · Cited by 193
Riewald, M., & Ruf, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500747200 · Cited by 187
McLaughlin, J. N., Shen, L., Holinstat, M., Brooks, J. D., DiBenedetto, E., & Hamm, H. E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414090200 · Cited by 186
Andrade-Gordon, P., Maryanoff, B. E., Derian, C. K., Zhang, H.-C., Addo, M. F., Darrow, A. L., Eckardt, A. J., Hoekstra, W. J., McComsey, D. F., Oksenberg, D., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12257 · Cited by 185
Santulli, R. J., Derian, C. K., Darrow, A. L., Tomko, K. A., Eckardt, A. J., Seiberg, M., Scarborough, R. M., & Andrade-Gordon, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9151 · Cited by 183
Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation.
Hung, D. T., Vu, T. K., Wheaton, V. I., Ishii, K., & Coughlin, S. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115721 · Cited by 183
Déry, O., Thoma, M. S., Wong, H., Grady, E. F., & Bunnett, N. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18524 · Cited by 176
Mechanisms of Cancer-Induced Thrombosis in Cancer
Rickles, F. R. (2006) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000093551 · Cited by 176
Hansen, K. K., Sherman, P. M., Cellars, L., Andrade-Gordon, P., Pan, Z., Baruch, A., Wallace, J. L., Hollenberg, M. D., & Vergnolle, N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409535102 · Cited by 176
Self-citationProtease-activated receptor-3 (PAR3) regulates PAR1 signaling by receptor dimerization
McLaughlin, J. N., Patterson, M. M., & Malik, A. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700763104 · Cited by 176
Luo, W., Wang, Y., & Reiser, G. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.08.002 · Cited by 173
Wang, H., Ubl, J. J., & Reiser, G. (2002) · Glia · doi:10.1002/glia.10012 · Cited by 173
Morrow, D. A., Scirica, B. M., Fox, K. A. A., Berman, G., Strony, J., Veltri, E., Bonaca, M. P., Fish, P., McCabe, C. H., & Braunwald, E. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.027 · Cited by 172
Neutrophil Elastase Acts as a Biased Agonist for Proteinase-activated Receptor-2 (PAR2)
Ramachandran, R., Mihara, K., Chung, H., Renaux, B., Lau, C. S., Muruve, D. A., DeFea, K. A., Bouvier, M., & Hollenberg, M. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201988 · Cited by 169
Self-citationCLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT
Vergnolle, N. (2005) · Gut · doi:10.1136/gut.2004.048876 · Cited by 166
Adam, E., Hansen, K. K., Astudillo, O. F., Coulon, L., Bex, F., Duhant, X., Jaumotte, E., Hollenberg, M. D., & Jacquet, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m507140200 · Cited by 166
Self-citationZwicker, J. I., Furie, B. C., & Furie, B. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.01.001 · Cited by 166
β‐arrestins and heterotrimeric G‐proteins: collaborators and competitors in signal transduction
DeFea, K. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707508 · Cited by 162
Self-citationDerian, C. K., Damiano, B. P., Addo, M. F., Darrow, A. L., D’Andrea, M. R., Nedelman, M., Zhang, H.-C., Maryanoff, B. E., & Andrade-Gordon, P. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.042663 · Cited by 161
Cellular assays as portals to seven-transmembrane receptor-based drug discovery
Kenakin, T. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2838 · Cited by 159
Soreide, K., Janssen, E., Körner, H., & Baak, J. (2006) · The Journal of Pathology · doi:10.1002/path.1999 · Cited by 158
Chambers, R. C., Dabbagh, K., McAnulty, R. J., GRAY, A. J., Blanc‐Brude, O., & Laurent, G. J. (1998) · Biochemical Journal · doi:10.1042/bj3330121 · Cited by 155
Sokolova, E., & Reiser, G. (2008) · Thrombosis and Haemostasis · doi:10.1160/th08-03-0131 · Cited by 153
Noorbakhsh, F., Tsutsui, S., Vergnolle, N., Boven, L. A., Shariat, N., Vodjgani, M., Warren, K. G., Andrade‐Gordon, P., Hollenberg, M. D., & Power, C. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052148 · Cited by 153
Self-citationSafety and Tolerability of Atopaxar in the Treatment of Patients With Acute Coronary Syndromes
O’Donoghue, M. L., Bhatt, D. L., Wiviott, S. D., Goodman, S. G., Fitzgerald, D. J., Angiolillo, D. J., Goto, S., Montalescot, G., Zeymer, U., Aylward, P. E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.000786 · Cited by 152
Chin, A. C., Vergnolle, N., MacNaughton, W. K., Wallace, J. L., Hollenberg, M. D., & Buret, A. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1831452100 · Cited by 149
Self-citationYang, E., Boire, A. A., Agarwal, A., Nguyen, N., O’Callaghan, K., Tu, P., Kuliopulos, A., & Covic, L. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0187 · Cited by 149
Hamilton, J. R., Frauman, A. G., & Cocks, T. M. (2001) · Circulation Research · doi:10.1161/hh1301.092661 · Cited by 148
Goto, S., Ogawa, H., Takeuchi, M., Flather, M. D., Bhatt, D. L., & on behalf of the J-LANCELOT (Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin) Investigators (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq320 · Cited by 146
Yasui, H., Gabazza, E. C., Tamaki, S., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.9911068 · Cited by 146
Development of Potent Thrombin Receptor Antagonist Peptides
Bernatowicz, M. S., Klimas, C. E., Hartl, K. S., Peluso, M., Allegretto, N. J., & Seiler, S. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960455s · Cited by 144
Protease‐activated receptor‐4: a novel mechanism of inflammatory pain modulation
Asfaha, S., Cénac, N., Houle, S., Altier, C., Papez, M. D., Nguyen, C., Steinhoff, M. S., Chapman, K., Zamponi, G. W., & Vergnolle, N. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706975 · Cited by 143
Proteinase-activated receptors in the nervous system
Noorbakhsh, F., Vergnolle, N., Hollenberg, M. D., & Power, C. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1255 · Cited by 143
Self-citationCaveolae are required for protease-selective signaling by protease-activated receptor–1
Russo, A., Soh, U. J. K., Paing, M. M., Arora, P., & Trejo, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810687106 · Cited by 142
Even‐Ram, S., Maoz, M., Pokroy, E., Reich, R., Katz, B., Gutwein, P., Altevogt, P., & Bar‐Shavit, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007027200 · Cited by 140
Role of the Thrombin Receptor's Cytoplasmic Tail in Intracellular Trafficking
Shapiro, M. J., Trejo, J., Zeng, D., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.51.32874 · Cited by 139
Down-Regulation of Protease-activated Receptor-1 Is Regulated by Sorting Nexin 1
Wang, Y., Zhou, Y., Szabó, K., Haft, C. R., & Trejo, J. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e01-11-0131 · Cited by 138
Proteinase-Activated Receptor-2 and Human Lung Epithelial Cells
Dulon, S., Candé, C., Bunnett, N. W., Hollenberg, M. D., Chignard, M., & Pidard, D. (2003) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.4908 · Cited by 137
Self-citationActivation of Protease-Activated Receptor-1 Triggers Astrogliosis after Brain Injury
Nicole, O., Goldshmidt, A., Hamill, C. E., Sorensen, S. D., Sastre, A. A., Lyuboslavsky, P. N., Hepler, J. R., McKeon, R. J., & Traynelis, S. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.5200-04.2005 · Cited by 133
Randomized Trial of Atopaxar in the Treatment of Patients With Coronary Artery Disease
Wiviott, S. D., Flather, M. D., O’Donoghue, M. L., Goto, S., Fitzgerald, D. J., Cura, F. A., Aylward, P. E., Guetta, V., Dudek, D., Contant, C. F., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.001404 · Cited by 133
Protease-activated receptors as drug targets in inflammation and pain
Vergnolle, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.05.004 · Cited by 132
Turgeon, V. L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00015-5 · Cited by 129
Ramsay, A. J., Dong, Y., Hunt, M. L., Linn, M., Samaratunga, H., Clements, J. A., & Hooper, J. D. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709493200 · Cited by 129
Paing, M. M., Johnston, C. A., Siderovski, D. P., & Trejo, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.8.3231-3242.2006 · Cited by 127
Committees, T. T. C. E. A. S. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.07.001 · Cited by 124
Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)
Suen, J. Y., Barry, G. D., Lohman, R., Halili, M. A., Cotterell, A. J., Le, G. T., & Fairlie, D. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01610.x · Cited by 123
Renesto, P., Si‐Tahar, M., Moniatte, M., Balloy, V., DORSSELAER, A. V., Pidard, D., & Chignard, M. (1997) · Blood · doi:10.1182/blood.v89.6.1944 · Cited by 121
Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins
Sevigny, L. M., Zhang, P., Bohm, A., Lazarides, K., Perides, G., Covic, L., & Kuliopulos, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017091108 · Cited by 120
Up-Regulation of Proteinase-Activated Receptor 1 Expression in Astrocytes During HIV Encephalitis
Boven, L. A., Vergnolle, N., Henry, S. D., Silva, C., Imai, Y., Holden, J. K., Warren, K. G., Hollenberg, M. D., & Power, C. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2638 · Cited by 118
Self-citationPersistent Protease-activated Receptor 4 Signaling Mediates Thrombin-induced Microglial Activation
Suo, Z., Wu, M., Citron, B. A., Gao, C., & Festoff, B. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302137200 · Cited by 115
Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
Οικονομοπούλου, Κ., Hansen, K. K., Saifeddine, M., Vergnolle, N., Téa, I., Blaber, M., Blaber, S. I., Scarisbrick, I. A., Diamandis, E. P., & Hollenberg, M. D. (2006) · Biological Chemistry · doi:10.1515/bc.2006.104 · Cited by 115
Self-citationEbeling, C., Forsythe, P., Ng, J., Gordon, J., Hollenberg, M. D., & Vliagoftis, H. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.11.042 · Cited by 113
Self-citationProtease-activated receptor-2 activation: a major actor in intestinal inflammation
Hyun, E., Andrade‐Gordon, P., Steinhoff, M. S., & Vergnolle, N. (2008) · Gut · doi:10.1136/gut.2008.150722 · Cited by 112
Andrade‐Gordon, P., Derian, C. K., Maryanoff, B. E., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29348-4 · Cited by 112
Vergnolle, N., Hollenberg, M. D., & Wallace, J. L. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702408 · Cited by 111
Self-citationNovel Agonists and Antagonists for Human Protease Activated Receptor 2
Barry, G. D., Suen, J. Y., Le, G. T., Cotterell, A. J., Reid, R. C., & Fairlie, D. P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100984y · Cited by 107
The non-stoichiometric floating receptor model for hormone sensitive adenylyl cyclase
de Haën, C. (1976) · Journal of Theoretical Biology · doi:10.1016/s0022-5193(76)80126-9 · Cited by 106
Thiyagarajan, M., Fernández, J. A., Lane, S. M., Griffin, J. H., & Zlokovic, B. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3485-08.2008 · Cited by 105
Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuli
Asfaha, S., Brussee, V., Chapman, K., Zochodne, D. W., & Vergnolle, N. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704568 · Cited by 104
Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis
Lohman, R., Cotterell, A. J., Suen, J. Y., Liu, L., Anh, T., Vesey, D. A., & Fairlie, D. P. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187062 · Cited by 103
G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells
Tiruppathì, C., Yan, W., Sandoval, R., Naqvi, T., Pronin, A. N., Benovic, J. L., & Malik, A. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7440 · Cited by 101
Arizmendi, N. G., Abel, M., Mihara, K., Davidson, C. E., Polley, D., Nadeem, A., Mays, T. Y. E., Gilmore, B., Walker, B., Gordon, J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903812 · Cited by 99
Self-citationAl‐Ani, B., Saifeddine, M., Kawabata, A., RENAUX, B. S., Mokashi, S., & Hollenberg, M. D. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34960-2 · Cited by 96
Self-citationWolfe, B. L., Marchese, A., & Trejo, J. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610154 · Cited by 95
Kato, Y., Kita, Y., Hirasawa-Taniyama, Y., et al. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01973-3 · Cited by 94
Trypsins and their role in carcinoma growth
Nyberg, P., Ylipalosaari, M., Sorsa, T. A., & Salo, T. A. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.12.024 · Cited by 94
Noorbakhsh, F., Vergnolle, N., McArthur, J. C., Silva, C., Vodjgani, M., Andrade‐Gordon, P., Hollenberg, M. D., & Power, C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.7320 · Cited by 93
Self-citationPlasticity-related serine proteases in the brain (review).
Yoshida, S., & Shiosaka, S. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.3.4.405 · Cited by 88
Mucosal sensitization to German cockroach involves protease-activated receptor-2
Page, K., Ledford, J. R., Zhou, P. H., Dienger, K. M., & Wills-Karp, M. A. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-62 · Cited by 85
Pharmacology, Biodistribution, and Efficacy of GPCR-Based Pepducins in Disease Models
Tressel, S. L., Κούκος, Γ., Tchernychev, B., Jacques, S. L., Covic, L., & Kuliopulos, A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-919-2_19 · Cited by 84
Kogushi, M., Dastros-Pitei, D., Flather, M. D., Bhatt, D. L., & Serebruany, V. L. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-12-0805 · Cited by 84
Selective Inhibition of Protease-activated Receptor 4-dependent Platelet Activation by YD-3
Wu, C., Hwang, T., Liao, C., et al. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613128 · Cited by 83
Rab5a and rab11a mediate agonist-induced trafficking of protease-activated receptor 2
Roosterman, D., Schmidlin, F., & Bunnett, N. W. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00540.2002 · Cited by 83
Moffatt, J. D., Jeffrey, K. L., & Cocks, T. M. (2002) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.26.6.4693 · Cited by 82
Hasdemir, B., Murphy, J. E., Cottrell, G. S., & Bunnett, N. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025692 · Cited by 81
Ricks, T. K., & Trejo, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.048942 · Cited by 79
Chen, C.-H., Paing, M. M., & Trejo, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310590200 · Cited by 77
Chen, B., Dores, M. R., Grimsey, N. J., Canto, I., Barker, B. L., & Trejo, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.299776 · Cited by 74
Kawabata, A., Kuroda, R., Nagata, N., Kawao, N., Masuko, T., Nishikawa, H., & Kawai, K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704211 · Cited by 74
Hollenberg, M. D., & Saifeddine, M. (2001) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y01-013 · Cited by 72
Self-citationProtease-Activated Receptor-2 Modulates Protease-Activated Receptor-1–Driven Neointimal Hyperplasia
Sevigny, L. M., Austin, K. M., Zhang, P., Kasuda, S., Κούκος, Γ., Sharifi, S., Covic, L., & Kuliopulos, A. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.238261 · Cited by 71
Hamilton, J. R., Nguyen, P. B., & Cocks, T. M. (1998) · Circulation Research · doi:10.1161/01.res.82.12.1306 · Cited by 70
Fernández, J. A., Griffin, J. H., Schuepbach, R. A., Feistritzer, C., & Riewald, M. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-10-0632 · Cited by 70
A Tyrosine-based Sorting Signal Regulates Intracellular Trafficking of Protease-activated Receptor-1
Paing, M. M., Temple, B. R. S., & Trejo, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401672200 · Cited by 69
Deficiency of PAR-2 Gene Increases Acute Focal Ischemic Brain Injury
Jin, G., Hayashi, T., Kawagoe, J., Takizawa, T., Nagata, T., Nagano, I., Syoji, M., & Abe, K. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600021 · Cited by 69
Al‐Ani, B., Saifeddine, M., Wijesuriya, S. J., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.702 · Cited by 69
Hasdemir, B., Bunnett, N. W., & Cottrell, G. S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702974200 · Cited by 66
Identification of an antithrombotic allosteric modulator that acts through helix 8 of PAR1
Dowal, L. M., Sim, D., Dilks, J. R., Blair, P. S., Beaudry, S., Denker, B. M., Κούκος, Γ., Kuliopulos, A., & Flaumenhaft, R. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014863108 · Cited by 62
Wang, Y., Luo, W., Stricker, R., & Reiser, G. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03950.x · Cited by 61
Deficiency of PAR4 Attenuates Cerebral Ischemia/Reperfusion Injury in Mice
Mao, Y., Zhang, M., Tuma, R. F., & Kunapuli, S. P. (2010) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.283 · Cited by 60
Evidence for the presence of functional protease activated receptor 4 (PAR 4 ) in the rat colon
Mulè, F., Pizzuti, R., Capparelli, A., & Vergnolle, N. (2004) · Gut · doi:10.1136/gut.2003.021899 · Cited by 60
Afkhami-Goli, A., Noorbakhsh, F., Keller, A. J., Vergnolle, N., Westaway, D. A., Jhamandas, J. H., Andrade‐Gordon, P., Hollenberg, M. D., Arab, H.-A., Dyck, R. H., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5493 · Cited by 60
Self-citationHollenberg, M. D., Saifeddine, M., Al‐Ani, B., et al. (1999) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y99-090 · Cited by 59
Self-citationModulation of Tissue Factor–Factor VIIa Signaling by Lipid Rafts and Caveolae
Awasthi, V., Mandal, S. K., Papanna, V., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.143438 · Cited by 58
Cénac, N., Cellars, L., Steinhoff, M. S., Andrade‐Gordon, P., Hollenberg, M. D., Wallace, J. L., Fiorucci, S., & Vergnolle, N. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000177506.71784.bd · Cited by 58
Self-citationYD‐3, a novel inhibitor of protease‐induced platelet activation
Wu, C., Huang, S., Hwang, T., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703437 · Cited by 57
Roy, S. S., Saifeddine, M., Loutzenhiser, R., et al. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701726 · Cited by 57
Cottrell, G. S., Amadesi, S., Pikios, S., Camerer, E., Willardsen, J. A., Murphy, B. R., Caughey, G. H., Wolters, P. J., Coughlin, S. R., Peterson, A., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.101 · Cited by 56
Protease-activated receptor 1-dependent neuronal damage involves NMDA receptor function
Hamill, C. E., Mannaioni, G., Lyuboslavsky, P. N., et al. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.023 · Cited by 56
Cattaruzza, F., Cénac, N., Barocelli, E., Impicciatore, M., Hyun, E., Vergnolle, N., & Sternini, C. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051098 · Cited by 56
Xue, M., Hollenberg, M. D., Demchuk, A. M., & Yong, V. W. (2009) · Stroke · doi:10.1161/strokeaha.108.540393 · Cited by 56
Self-citationDeng, X., Mercer, P. F., Scotton, C. J., Gilchrist, A., & Chambers, R. C. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-07-0720 · Cited by 56
Kallikrein-Related Peptidase 4
Gratio, V., Beaufort, N., Seiz, L., Maier, J., Virca, G. D., Debela, M., Grebenchtchikov, N. I., Magdolen, V., & Darmoul, D. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090523 · Cited by 54
Arrestin-2 Differentially Regulates PAR4 and ADP Receptor Signaling in Platelets
Li, D., D'Angelo, L., Chavez, M., & Woulfe, D. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118018 · Cited by 54
Roles and interactions among protease-activated receptors and P2ry12 in hemostasis and thrombosis
Cornelissen, I., Palmer, D., David, T., Wilsbacher, L. D., Concengco, C., Conley, P. B., Pandey, A., & Coughlin, S. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013309107 · Cited by 53
Shapiro, M. J., & Coughlin, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.44.29009 · Cited by 53
Identification and Characterization of Novel Small-Molecule Protease-Activated Receptor 2 Agonists
Gardell, L. R., Ma, J., Seitzberg, J. G., Knapp, A. E., Schiffer, H. H., Tabatabaei, A., Davis, C. N., Owens, M., Clemons, B., Wong, K. K., et al. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142570 · Cited by 53
Hamill, C. E., Caudle, W. M., Richardson, J. R., Yuan, H., Pennell, K. D., Greene, J. G., Miller, G. W., & Traynelis, S. F. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038158 · Cited by 52
Suen, J. Y., Gardiner, B., Grimmond, S. M., & Fairlie, D. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013809 · Cited by 51
Lau, C. S., Lytle, C. Y., Straus, D. S., & DeFea, K. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00162.2010 · Cited by 51
Self-citationDual effect mediated by protease‐activated receptors on the mechanical activity of rat colon
Mulè, F., Baffi, M. C., & Cerra, M. C. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704746 · Cited by 51
Henrich‐Noack, P., Riek‐Burchardt, M., Baldauf, K., Reiser, G., & Reymann, K. G. (2006) · Brain Research · doi:10.1016/j.brainres.2005.10.100 · Cited by 50
Gratio, V., Loriot, C., Virca, G. D., Οικονομοπούλου, Κ., Walker, F., Diamandis, E. P., Hollenberg, M. D., & Darmoul, D. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.07.016 · Cited by 50
Self-citationKanke, T., Kabeya, M., Kubo, S., Kondo, S., Yasuoka, K., Tagashira, J., Ishiwata, H., Saka, M., Furuyama, T., Nishiyama, T., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00342.x · Cited by 49
Buresi, M. C., Buret, A. G., Hollenberg, M. D., & MacNaughton, W. K. (2002) · The FASEB Journal · doi:10.1096/fj.02-0039com · Cited by 49
Self-citationProteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation
Russell, F. A., & McDougall, J. J. (2009) · Inflammation Research · doi:10.1007/s00011-009-8087-0 · Cited by 49
RWJ‐58259: A Selective Antagonist of Protease Activated Receptor‐1
Damiano, B. P., Derian, C. K., Maryanoff, B. E., et al. (2003) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2003.tb00124.x · Cited by 48
Laniyonu, A. A., & Hollenberg, M. D. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb14957.x · Cited by 48
Self-citationvan der Merwe, J. Q., Hollenberg, M. D., & MacNaughton, W. K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00303.2007 · Cited by 48
Self-citationChieng-Yane, P., Bocquet, A., Létienne, R., Bourbon, T., Sablayrolles, S., Perez, M., Hatem, S. N., Lompré, A., Grand, B. L., & David‐Dufilho, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.175182 · Cited by 46
Seatter, M. J., Drummond, R. M., Kanke, T., et al. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00095-0 · Cited by 44
Goh, F. G., Ng, P. Y., Nilsson, M., Kanke, T., & Plevin, R. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00415.x · Cited by 43
Perez, M., Lamothe, M., Maraval, C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900553j · Cited by 43
The role of PAR4 in thrombin-induced thromboxane production in human platelets
Wu, C., Hwang, T., Liao, C., Kuo, S., Lee, F., & Teng, C. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-02-0103 · Cited by 42
Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives
Chen, H., Kuo, S., Teng, C., et al. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.10.070 · Cited by 41
Moffatt, J. D., & Cocks, T. M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702157 · Cited by 41
Maryanoff, B. E., Zhang, H., Andrade‐Gordon, P., et al. (2003) · Current Medicinal Chemistry - Cardiovascular & Hematological Agents · doi:10.2174/1568016033356724 · Cited by 41
DeFea, K., Schmidlin, F., Déry, O., et al. (2000) · Biochemical Society Transactions · doi:10.1042/bst0280419 · Cited by 41
Self-citationKagota, S., Chia, E. W., & McGuire, J. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01356.x · Cited by 40
Gan, J., Greenwood, S., Cobb, S., & Bushell, T. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01293.x · Cited by 38
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
High-resolution crystal structure of human protease-activated receptor 1
Zhang, C., Srinivasan, Y., Arlow, D. H., Fung, J. J., Palmer, D., Zheng, Y., Green, H. F., Pandey, A., Dror, R. O., Shaw, D. E., et al. (2012) · Nature · doi:10.1038/nature11701 · Cited by 455
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
Peterson, Y. K., & Luttrell, L. M. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013367 · Cited by 422
Inflammation, obesity, and thrombosis
Samad, F., & Ruf, W. (2013) · Blood · doi:10.1182/blood-2013-05-427708 · Cited by 414
New Paradigms in Type 2 Immunity
Pulendran, B., & Artis, D. (2012) · Science · doi:10.1126/science.1221064 · Cited by 401
Metadata
- Authors
- Ramachandran, R., Noorbakhsh, F., DeFea, K., & Hollenberg, M. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-01
- Volume
- 11
- Issue
- 1
- Pages
- 69-86
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2085176272
- Cited by
- 312
- References
- 220
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.